Antonic Vlado, Mittermayr Rainer, Schaden Wolfgang, Stojadinovic Alexander
Henry M. Jackson Foundation for Advancement in Military Medicine, Rockville, MD; Combat Wound Initiative Program, Walter Reed Army Medical Center, Washington, DC; Email:
Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, Austria; AUVA Trauma Center, Meidling, Vienna, Austria.
Wounds. 2011 Jul;23(7):204-15.
Objective. Soft tissue wound healing is a complex and well-orchestrated sequence of events on multiple biological levels involving systemic, cellular, and molecular signals. The physiological process of wound healing leads to full tissue repair and regeneration with nearly complete restoration of tissue integrity and functionality. Wounds, particularly among the elderly population, can show delayed or disturbed healing; however, delayed or disturbed healing is also evident in patients with comorbidities such as diabetes, atherosclerosis, venous/arterial insufficiency, reduced mobility due to chronic infirmity, and hypercholesterolemia. Chronic wounds are conditions, which include a wide range of inflammatory and degenerative conditions of the musculoskeletal system. Management of chronic, difficult to heal, or non-healing soft tissue wounds requires a multidisciplinary approach. Often these treatment options have inconsistent and irregular outcomes. Poor response or failure to conservative treatments places a substantial burden on patients, their families, the healthcare system, and society in general. Therefore, the development of a new, effective method of treatment to improve healing of problematic wounds and reduce treatment-related costs is extremely valuable. One such therapy is Extracorporeal Shockwave Therapy (ESWT). ESWT acts through mechanotransduction, which produces therapeutic benefits through complex biological pathways including neovascularization and tissue regeneration in the therapeutic target. Published data thus far suggest that the application of ESWT for soft tissue indications is safe, reliable, cost-effective, and clinically efficacious. The exact biological effects of ESWT on human cells are not completely understood, but are currently undergoing further study. The aim of this review is to provide a general overview of shockwave therapy and its role in the treatment of acute and chronic soft tissue wounds. .
目的。软组织伤口愈合是一个复杂且精心编排的多生物学水平事件序列,涉及全身、细胞和分子信号。伤口愈合的生理过程会导致组织完全修复和再生,组织完整性和功能几乎完全恢复。伤口,尤其是在老年人群中,可能会出现愈合延迟或紊乱的情况;然而,在患有糖尿病、动脉粥样硬化、静脉/动脉功能不全、因慢性体弱导致活动能力下降以及高胆固醇血症等合并症的患者中,愈合延迟或紊乱也很明显。慢性伤口是包括肌肉骨骼系统广泛炎症和退行性疾病的病症。慢性、难愈合或不愈合的软组织伤口的管理需要多学科方法。通常这些治疗选择的结果不一致且不规律。对保守治疗反应不佳或失败给患者及其家庭、医疗保健系统以及整个社会带来了沉重负担。因此,开发一种新的有效治疗方法以改善有问题伤口的愈合并降低治疗相关成本极具价值。一种这样的疗法是体外冲击波疗法(ESWT)。ESWT通过机械转导起作用,它通过包括治疗靶点处的新血管形成和组织再生在内的复杂生物学途径产生治疗益处。迄今为止发表的数据表明,ESWT用于软组织适应症是安全、可靠、具有成本效益且临床有效的。ESWT对人体细胞的确切生物学效应尚未完全了解,但目前正在进一步研究。本综述的目的是提供冲击波疗法及其在急性和慢性软组织伤口治疗中的作用的概述。